by Igor Hajdukovic | Sep 18, 2026 | Uncategorized
The legal operation of a professional fibroblast device in Canada is no longer a matter of preference but a strict requirement of federal law. You’ve likely seen the surge in demand for non-surgical tissue sublimation, yet the market remains saturated with...
by Igor Hajdukovic | Sep 17, 2026 | Uncategorized
Did you know that the precision difference between a predictable non-surgical blepharoplasty and an adverse clinical outcome often comes down to just 0.9 millimetres? While conventional alternating current devices create a broad 1.0 mm heat-affected zone, patented...
by Igor Hajdukovic | Sep 16, 2026 | Uncategorized
In 2026, the most resilient medical practices aren’t those with the most expensive laser suites, but those that prioritize low-overhead, multi-specialty technology. You’ve likely felt the mounting pressure of rising overhead costs and the diminishing...
by Igor Hajdukovic | Sep 15, 2026 | Uncategorized
If you believe that any device marketed as a “fibroblast” tool is legally permitted for clinical use in Canada, you’re unintentionally risking your medical licence and your patients’ safety. Understanding the specific Health Canada requirements...
by Igor Hajdukovic | Sep 14, 2026 | Uncategorized
Investing in an unverified plasma pen might seem like a cost-effective entry into aesthetics, but it often exposes a Canadian practice to significant regulatory risk and inconsistent clinical outcomes. You’ve likely noticed the market is saturated with...
